
    
      Single-site, open-labeled study. Twenty two subjects will be enrolled into the healthy adult
      group and twenty two subjects into the dry eye group. Each subject will be in the study for
      approximately 2 weeks (treatment) and seen at three study Visits: Visit 1 (Day 0, Baseline),
      Visit 2 (Day 7 +/- 1) and Visit 3 (Day 14 +/- 1). Dosing regimen is 1-2 drops into each eye,
      four times daily, for two weeks. Assessments will be comprised of visual acuity, slit lamp
      biomicroscopy, fluorescein corneal staining, and product comfort.
    
  